Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FLHY8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,290
Award facts
- Contract value 100% obligated
- $13,290.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,290.16 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose auto-injector pens. This firm fixed-price delivery order, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The product will be delivered to the company's corporate office location in Conshohocken, PA.
This delivery order falls under AmerisourceBergen Drug Corp's prime Indefinite Delivery/Indefinite Quantity contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The award of Cosentyx, an immunosuppressant medication used for autoimmune conditions, exemplifies the company's role in delivering specialty pharmaceuticals essential to federal medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FLHY8?
SPE2DB25FLHY8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FLHY8 worth?
The government has obligated $13,290 on SPE2DB25FLHY8.
Is contract SPE2DB25FLHY8 an order under another contract?
Yes. SPE2DB25FLHY8 is a delivery order under SPE2DB22D1002, an indefinite delivery contract.
Was contract SPE2DB25FLHY8 competed?
The extent of competition for SPE2DB25FLHY8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award